pharmaceutical giant Moderna said its COVID-19 vaccine protects against two new variants of the coronavirus. The company said the vaccine triggered an immune response to "all key emerging variants," including those first identified in the UK and South Africa. The researchers looked ...
A new report accuses American drugmaker Moderna of prioritizing profits from COVID-19 vaccines by keeping poor countries waiting. The New York Times says the vaccine maker has sold most of its doses to wealthier nations. Only one million doses have gone to low-income countries...
Moderna Inc said on Monday its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second U.S. company in a week to report results that far exceed expectations. Together with Pfizer Inc's vaccine, also shown to...
Moderna has a $1.525 billion contract to provide the United States with 100 million doses of the vaccine throughOperation Warp Speed, the government’s fast-track program for Covid-19 vaccines, therapeutics, and diagnostics. The contract gives the U.S. government an option to purchase ...
The Moderna COVID-19 Vaccine has emergency authorization from the FDA for active immunization to prevent COVID-19 in individuals 18 and older. The vaccine uses a new technology; synthetic mRNA directs the body to create harmless virus proteins to train y
The Singapore government has approved the Moderna Covid-19 vaccine for use here, and the first shipment is expected by Mar 2021.
Kaiser Permanente research published on December 15, 2021 in The British Medical Journal showed 2 doses of Moderna COVID-19 vaccine were highly effective against all SARS-CoV-2 variants; however, vaccine effectiveness against the delta variant moderately
The Moderna COVID-19 vaccine 2024-2025 Formula is an mRNA COVID-19 vaccine that may help your child develop immunity to SARS-CoV-2, the virus that causes COVID-19. The Moderna COVID-19 vaccine has been granted Emergency Use Authorization (EUA) for childr
Moderna's CEO said the company's new COVID-19 vaccine may prevent infection for years. While speaking at a virtual event by Oddo BHF, a financial service group, Moderna CEO Stephane Bancel said the once-believed "nightmare scenario" that the vaccine won't work is now out the window. "...
Prior research has shown that Pfizer's and Johnson & Johnson's vaccines were effective against COVID-19 for at least six months. In this new effort, the researchers sought to find out if the same is true for the Moderna vaccine.